Single- And-Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CRN00808 in Healthy Volunteers and to Determine the Effect of CRN00808 on Midazolam Pharmacokinetics

Trial Profile

Single- And-Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CRN00808 in Healthy Volunteers and to Determine the Effect of CRN00808 on Midazolam Pharmacokinetics

Recruiting
Phase of Trial: Phase I

Latest Information Update: 13 Sep 2017

At a glance

  • Drugs CRN-00808 (Primary) ; Midazolam
  • Indications Acromegaly
  • Focus Adverse reactions
  • Sponsors Crinetics Pharmaceuticals
  • Most Recent Events

    • 11 Sep 2017 New trial record
    • 08 Sep 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top